$2.49 Billion in Sales Expected for Owens & Minor, Inc. (NYSE:OMI) This Quarter

Equities research analysts predict that Owens & Minor, Inc. (NYSE:OMI) will announce sales of $2.49 billion for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Owens & Minor’s earnings. The lowest sales estimate is $2.47 billion and the highest is $2.52 billion. Owens & Minor posted sales of $2.54 billion during the same quarter last year, which suggests a negative year-over-year growth rate of 2%. The company is scheduled to report its next quarterly earnings report on Tuesday, February 18th.

On average, analysts expect that Owens & Minor will report full-year sales of $9.84 billion for the current fiscal year, with estimates ranging from $9.81 billion to $9.86 billion. For the next financial year, analysts forecast that the business will post sales of $9.83 billion, with estimates ranging from $9.76 billion to $9.91 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that that provide coverage for Owens & Minor.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.20 EPS for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.01. The firm had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.45 billion. Owens & Minor had a positive return on equity of 4.89% and a negative net margin of 2.88%. The company’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.32 earnings per share.

Several research firms have commented on OMI. Bank of America boosted their price objective on Owens & Minor from $4.00 to $7.50 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Zacks Investment Research cut Owens & Minor from a “strong-buy” rating to a “hold” rating in a report on Saturday, November 9th. Finally, ValuEngine downgraded Owens & Minor from a “strong-buy” rating to a “buy” rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. Owens & Minor presently has an average rating of “Hold” and a consensus price target of $6.90.

Large investors have recently added to or reduced their stakes in the company. Bank of Montreal Can boosted its position in shares of Owens & Minor by 66.9% during the 2nd quarter. Bank of Montreal Can now owns 8,066 shares of the company’s stock valued at $26,000 after purchasing an additional 3,233 shares in the last quarter. Stone Ridge Asset Management LLC bought a new position in shares of Owens & Minor during the 2nd quarter worth about $50,000. Royal Bank of Canada boosted its position in shares of Owens & Minor by 37.4% during the 2nd quarter. Royal Bank of Canada now owns 17,241 shares of the company’s stock worth $55,000 after purchasing an additional 4,689 shares in the last quarter. First Trust Advisors LP acquired a new stake in shares of Owens & Minor in the 1st quarter valued at about $56,000. Finally, Taylor Hoffman Wealth Management grew its stake in shares of Owens & Minor by 131.3% in the 3rd quarter. Taylor Hoffman Wealth Management now owns 13,874 shares of the company’s stock valued at $81,000 after buying an additional 7,875 shares during the period. 88.15% of the stock is owned by institutional investors and hedge funds.

Shares of NYSE:OMI traded up $0.03 during midday trading on Monday, reaching $7.01. The company’s stock had a trading volume of 58,258 shares, compared to its average volume of 1,565,050. The company has a quick ratio of 0.85, a current ratio of 1.74 and a debt-to-equity ratio of 3.57. The stock has a fifty day moving average of $6.79 and a 200 day moving average of $4.84. Owens & Minor has a twelve month low of $2.43 and a twelve month high of $8.43. The firm has a market capitalization of $416.08 million, a PE ratio of 6.10 and a beta of 1.43.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

See Also: Commodities

Get a free copy of the Zacks research report on Owens & Minor (OMI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit